Daiichi Sankyo
Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.
DitchCarbon Score
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo's score of 41 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo's reported carbon emissions
In 2023, Daiichi Sankyo reported total carbon emissions of approximately 109,239,000 kg CO2e globally, with Scope 1 emissions at about 85,245,000 kg CO2e, Scope 2 emissions at around 23,994,000 kg CO2e, and significant Scope 3 emissions reaching approximately 3,887,790,000 kg CO2e. In Japan, the company recorded total emissions of about 66,020,000 kg CO2e, with Scope 1 at approximately 63,848,000 kg CO2e and Scope 2 at about 2,173,000 kg CO2e. Daiichi Sankyo has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 63% by FY2030 from a FY2015 baseline. Additionally, the company plans to increase its sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, Daiichi Sankyo is committed to ensuring that 70.6% of its suppliers by emissions will have science-based targets by FY2025. Previously, the company had also committed to a 37.5% reduction in Scope 1 and 2 emissions by 2030 from a 2015 base year, alongside a goal for 90% of key suppliers to establish GHG reduction targets by fiscal year 2020. These initiatives reflect Daiichi Sankyo's dedication to aligning with global climate goals and reducing its overall carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 217,257,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 304,293,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
